Quick Facts

Share SHARE

Bayer HealthCare, an unit of German conglomerate Bayer AG (BYR.L, BAYRY.PK, BAYZF.PK), reported results from the X-VeRT study showing that once-daily Xarelto is an effective and well-tolerated alternative to dose-adjusted vitamin K antagonists or VKAs, such as warfarin in patients with non-valvular atrial...

Sandvik Group (SDVKF.PK, SDVKY.PK), a Swedish tools, service and technical solutions company, Tuesday announced that its unit Sandvik Materials Technology is divesting its distribution business in Australia and New Zealand to Vulcan Steel Ltd., a privately owned steel distributor with operations. The...

Swiss drug maker Novartis AG (NVS) reported that a wealth of new data from its respiratory portfolio would be presented at the European Respiratory Society or ERS International Congress, September 6-10, in Munich, Germany. Totally, 44 abstracts would be presented by Novartis, representing more than any...

Moelis & Co. (MC), an independent investment bank, Tuesday announced the appointment of Eric Cantor, former United States Representative for Virginia's 7th Congressional District and former House Majority Leader, as Vice Chairman and Managing Director. Cantor will also be elected to the Moelis & Company...

Digital security firm Gemalto (GTOFF.PK) Tuesday said it is providing M2M connectivity for SOLARKIOSK, a compact, solar powered station transported onboard a mobile vehicle. This cabin features photovoltaic panels across its roof to generate sustainable energy in areas outside conventional power...

Telecom giant AT&T (T) Tuesday said it has turned on the nation's most reliable 4G LTE network in Tullahoma, thus bringing customers the latest generation of wireless network technology. The benefits of AT&T's 4G LTE include faster speeds, reliability, cool new devices, faster response time and more...

Detroit-based software developer Compuware Corp. (CPWR) is close to a deal to sell itself, the Wall Street Journal reported, quoting people familiar with the matter. The company is in advanced talks with a private-equity buyer, and a deal may be announced as soon as Tuesday. While the identity...

Ballard Power Systems (BLDP,BLD.TO) announced the appointment of Randall MacEwen to replace John Sheridan as President and Chief Executive Officer, effective October 6, 2014. John Sheridan planned to retire at yearend and will continue to serve as an employee in an advisory capacity and on the Board...

A special Chinese investigation team questioned Microsoft's (MSFT) Vice President David Chen and other staff members on the company's alleged monopoly activities in China, and asked the company to give a written explanation within 20 days. The state-run Xinhua news agency reported that the team led...

Scientific Games Corp. (SGMS) Monday said it has named Dan Savage as its Vice President, Corporate Marketing. The company said Savage will work closely with the its Gaming, Lottery and Interactive groups to identify, evaluate and leverage opportunities to increase player appeal and positioning in...

Insurance giant American International Group Inc. (AIG) said that Peter Hancock has assumed the role of President and Chief Executive Officer of the company, and has joined AIG's Board of Directors. Hancock succeeds Robert Benmosche, who retired and now serves as an advisor to AIG. Hancock, 56, joined...

Apple Inc. (AAPL) plans to turn its next iPhone into a mobile wallet through a partnership with major payment networks, banks and retailers, Bloomberg reported citing a person familiar with the matter. The agreement includes Visa Inc. (V), MasterCard Inc. (MA) and American Express Co. (AXP) and will...

Ablynx (ABLYF.PK) said Monday that it has expanded its relationship with Eddingpharm, China-based specialty pharmaceutical company, by granting Eddingpharm an exclusive, royalty-bearing license to develop and commercialise Ablynx's anti-TNFa Nanobody, ozoralizumab (ATN-103), in the mainland of the People's...

French pharmaceutical firm Ipsen (IPSEY) said Monday that the U.S. Food and Drug Administration or FDA has accepted and granted priority review of its supplemental New Drug Application or sNDA for Somatuline Depot 120mg injection in the treatment of gastroenteropancreatic neuroendocrine tumors or GEP-NETs. The...

UCB announced that the U.S. Food and Drug Administration has approved a supplemental new drug application (sNDA) for VIMPAT (lacosamide) C-V as monotherapy in the treatment of partial-onset seizures in patients with epilepsy aged 17 years and older. This is a new indication for VIMPAT which is already...